Company Overview
- Headquarters
- 2005 Market Street 39th Floor, Philadelphia PA
- Website
- passagebio.com/home/default.aspx
- Phone
- (267) 866-****
- Employees
- 89
- Founded in
- 2017
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$20B
Who is Passage Bio
Passage Bio is a genetics medicine company headquartered in Philadelphia, Pennsylvania. The company employs 89 people and has generated $20 million in revenue. Passage Bio is focused on developing cutting-edge therapeutics for disorders of the central nervous system (CNS). The company's gene therapy programs target a range of devastating diseases, including GM1 gangliosidosis, Krabbe disease, and frontotemporal dementia. Passage Bio's innovative approach is informed by its collaboration with the University of Pennsylvania's Gene Therapy Program and Orphan Disease Center. Passage Bio is also expanding its operations with a new laboratory at the Princeton West Innovation Campus in Hopewell, New Jersey, further solidifying its commitment to advancing gene therapy innovation. For more information about Passage Bio and its groundbreaking work, please visit www.passagebio.com.
Company Leadership
Passage Bio Tech Stack
Companies Similar to Passage Bio
Analyze industry trends and opportunities by examining competitors and companies comparable to Passage Bio, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 20M | 39 | Roseville, MN | 2010 | |
| 20M | Jupiter Farms, FL | |||
| 20M | 83 | Richmond Hill, NH | 1979 | |
| 20M | 70 | Davis, CA | 2006 | |
| 20M | 20 | Lexington, KY |